Comparison of Objective Prognostic Score and Palliative Prognostic Score performance in inpatients with advanced cancer in Japan and Korea
Comparison of Objective Prognostic Score and Palliative Prognostic Score performance in inpatients with advanced cancer in Japan and Korea
复制标题
日本和韩国晚期癌症住院患者客观预后评分与姑息性预后评分表现的比较
DOI：
10.1017/s1478951521001589
复制
发表时间：
2022
影响因子：
2.2
通讯作者：
Inoue A
中科院分区：
文献类型：
--
作者：
Hiratsuka Y;Kim D;Suh SY;Kim SH;Yoon SJ;Koh SJ;Park SA;Seo JY;Kwon JH;Park J;Park Y;Hwang SW;Lee ES;Choi H;Ahn HY;Cheng SY;Chen PJ;Yamaguchi T;Morita T;Tsuneto S;Mori M;Inoue A
目的准确的预后对患者及其家属做好临终准备具有重要意义。客观预后评分（OPS）是一种易于使用的工具，不需要临床医生的生存预测（CPS），而姑息性预后评分（PaP）需要CPS。因此，缺乏经验的临床医生可能会犹豫是否使用PaP。我们旨在评估三个东亚国家姑息治疗单位（PCUs）住院患者OPS与PaP的准确性。方法本研究是一项跨文化、多中心队列研究的二次分析。我们于2017年至2018年在日本、韩国和台湾的PCUs招募了晚期癌症住院患者。我们计算受者工作特征曲线下面积（AUROC），比较OPS和PaP的准确性。结果分析了日本和韩国33个pcu的1628例住院患者。71.7%的日本患者和80.0%的韩国患者计算了OPS和PaP。在台湾，81.6%的患者计算PaP。日本OPS患者的3周生存AUROC为0.74，韩国OPS患者为0.68，日本PaP患者为0.80，韩国PaP患者为0.73。日本OPS患者30天生存AUROC为0.70，韩国OPS患者为0.71，日本PaP患者为0.79，韩国PaP患者为0.74。结果在日本和韩国，OPS和PaP均表现良好。与PaP相比，OPS对于缺乏经验且不愿评估CPS的医生可能更有用。
Objective Accurate prognostication is important for patients and their families to prepare for the end of life. Objective Prognostic Score (OPS) is an easy-to-use tool that does not require the clinicians’ prediction of survival (CPS), whereas Palliative Prognostic Score (PaP) needs CPS. Thus, inexperienced clinicians may hesitate to use PaP. We aimed to evaluate the accuracy of OPS compared with PaP in inpatients in palliative care units (PCUs) in three East Asian countries. Method This study was a secondary analysis of a cross-cultural, multicenter cohort study. We enrolled inpatients with far-advanced cancer in PCUs in Japan, Korea, and Taiwan from 2017 to 2018. We calculated the area under the receiver operating characteristics (AUROC) curve to compare the accuracy of OPS and PaP. Results A total of 1,628 inpatients in 33 PCUs in Japan and Korea were analyzed. OPS and PaP were calculated in 71.7% of the Japanese patients and 80.0% of the Korean patients. In Taiwan, PaP was calculated for 81.6% of the patients. The AUROC for 3-week survival was 0.74 for OPS in Japan, 0.68 for OPS in Korea, 0.80 for PaP in Japan, and 0.73 for PaP in Korea. The AUROC for 30-day survival was 0.70 for OPS in Japan, 0.71 for OPS in Korea, 0.79 for PaP in Japan, and 0.74 for PaP in Korea. Significance of results Both OPS and PaP showed good performance in Japan and Korea. Compared with PaP, OPS could be more useful for inexperienced physicians who hesitate to estimate CPS.
登录
查看更多内容
影响因子：
3.7
作者：
Stone P;Vickerstaff V;Kalpakidou A;Todd C;Griffiths J;Keeley V;Spencer K;Buckle P;Finlay D;Omar RZ
通讯作者：
Omar RZ
韩国癌症患者存活数周的预期寿命预测评分的准确性比较
DOI：
10.1177/1049909113503486
发表时间：
2014
期刊：
American Journal of Hospice and Palliative Medicine®
影响因子：
--
作者：
Seok;J. Jung;Jong;Sung;Samyong Kim
通讯作者：
Samyong Kim
影响因子：
4.4
作者：
Tavares, Teresa;Oliveira, Margarida;Rocha, Ceu
通讯作者：
Rocha, Ceu
韩国晚期癌症住院患者客观预后评分的前瞻性验证：一项多中心研究。
DOI：
--
发表时间：
2017
期刊：
影响因子：
--
作者：
YoonSeok Joon;SuhSang;L. Joo;ParkJeanno;HwangSunwook;LeeSanghee Shiny;AhnHong Yup;KohSu;P. Uk
通讯作者：
P. Uk
在估计末期癌症患者的寿命时，临床生存预测比卡诺夫斯基表现状态更准确。
影响因子：
8.4
作者：
M. Maltoni;O. Nanni;S. Derni;M. Innocenti;L. Fabbri;N. Riva;R. Maltoni;D. Amadori
通讯作者：
D. Amadori